Status:

TERMINATED

Reducing Suicide Risk in Older Veterans Using Problem Solving Therapy

Lead Sponsor:

VA Office of Research and Development

Conditions:

Suicidal Ideation

Depressive Disorder

Eligibility:

All Genders

55+ years

Phase:

NA

Brief Summary

Suicide is a national crisis, especially among older Veterans for whom evidence-based suicide prevention efforts are lacking. This proposal responds to the national priority to develop and improve int...

Detailed Description

The proposed randomized control trial will examine the efficacy of a brief behavioral treatment for reducing suicidal ideation and for increasing reasons for living in older Veterans at risk for suici...

Eligibility Criteria

Inclusion

  • \>= 55 years old
  • SI (past month) on the C-SSRS
  • No SI or imminent risk (will be excluded)
  • Eligibility now includes non-specific active suicidal thoughts to active SI with some planning (on C-SSRS item 3: "Have you been thinking about how you might do this") and/or some intent to act (on C-SSRS item 4: "Have you had these thoughts and had some intention of acting on them?") provided that those endorsing item 4 have an established relationship with a psychiatrist aware of this intent level (who is not also performing psychotherapy)
  • Those endorsing C-SSRS item 5: "Do you intend to carry out this plan?" would be considered at imminent risk and excluded
  • Presence of DSM-5 depressive disorder or anxiety disorder, specified or unspecified, or PTSD or subthreshold PTSD.
  • No diagnosis of dementia; evidence that cognitive impairment is not indicative of possible dementia based on a negative cognitive telephone screen (\<10 errors on the Blessed cognitive screen)
  • No diagnosis on MINI or medical record for psychotic symptoms or disorders, bipolar disorder, or severe OCD (mild or moderate OCD will be eligible)
  • No history of head injury past 12 months
  • No severe or unstable chronic medical illness or other severe or unstable respiratory, cardiovascular, neurologic, hepatic, hematopoietic, gastrointestinal or metabolic dysfunction
  • AUDIT Total score \<15 for men or \<13 for women (no current alcohol use disorder)
  • No substance use disorder of any type for illicit substances, no moderate or severe substance use disorder for cannabis/marijuana - on the MINI.
  • No prominent homicidal ideation
  • English language proficiency to engage in treatment
  • Sensory abilities sufficiently intact to engage in assessment and treatment
  • Not currently enrolled in individual psychotherapy for a mental health issue. Participants who are receiving mental health care are eligible if their current care includes treatment from a psychiatrist, supportive therapy, peer counseling or support, or participating in psychoeducational groups.
  • No current prescription for anti-psychotics if prescribed for a psychotic disorder
  • Anti-psychotics for depression without psychosis are eligible
  • Psychotropic medications (e.g., SSRIs) are also eligible

Exclusion

  • \< 55 years old
  • No SI (past month) or imminent risk on the C-SSRS will be excluded. Those endorsing C-SSRS item 5: "Do you intend to carry out this plan?" would be considered at imminent risk and excluded
  • No DSM-5 depressive disorder or anxiety disorder, or PTSD or subthreshold PTSD
  • Diagnosis of dementia; evidence that cognitive impairment is indicative of possible dementia based on a positive cognitive telephone screen (\>=10 errors on the Blessed cognitive screen)
  • Diagnosis on MINI or medical record for psychotic symptoms or disorders, bipolar disorder, or severe OCD (mild or moderate OCD will be eligible)
  • History of head injury past 12 months
  • Severe or unstable chronic medical illness or other severe or unstable respiratory, cardiovascular, neurologic, hepatic, hematopoietic, gastrointestinal or metabolic dysfunction
  • AUDIT Total score \>14 for men or \>12 for women (no current alcohol use disorder)
  • Substance use disorder of any type for illicit substances, moderate or severe substance use disorder for cannabis/marijuana - on the MINI.
  • Prominent homicidal ideation
  • Lacking English language proficiency to engage in treatment
  • Sensory abilities not sufficiently intact to engage in assessment and treatment
  • Currently enrolled in individual psychotherapy for a mental health issue. Participants who are receiving mental health care are eligible if their current care includes treatment from a psychiatrist, supportive therapy, peer counseling or support, or participating in psychoeducational groups.
  • Current prescription for anti-psychotics if prescribed for a psychotic disorder, and not prescribed for depression without psychosis

Key Trial Info

Start Date :

January 24 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 5 2025

Estimated Enrollment :

117 Patients enrolled

Trial Details

Trial ID

NCT04763330

Start Date

January 24 2022

End Date

November 5 2025

Last Update

January 9 2026

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

VA Palo Alto Health Care System, Palo Alto, CA

Palo Alto, California, United States, 94304-1207

2

Syracuse VA Medical Center, Syracuse, NY

Syracuse, New York, United States, 13210